Migraine and headache in the WHO GBD study

The Global Burden of Disease (GBD) study takes a standardised approach to estimating incidence, prevalence, and years lived with disability (YLD) of various diseases and health states, often segmenting the data by age, sex, year, and geography.^{[GBD, 2017]} An analysis of the GBD survey data from 1990–2016 looked at trends in migraine prevalence and burden across those years, specifically focusing on the implications of these changes on future GBD surveys and migraine treatments.^{[GBD, 2016]} As shown on the slide, from 1990–2016 the YLD-burden of migraine increased by more than 50%.^{[GBD, 2016]}

References:
GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018; 17 (11): 954–976.

GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1789–1858.